Position in PFSA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,637
+$15,637 QoQ
Shares Held
308
-99.9% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFSA Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $3,447,350,274 across 95 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
8,597,227 | $780,112,377 | |
| 2 | MDT |
Medtronic plc
|
5,373,877 | $420,398,397 | |
| 3 | EW |
Edwards Lifesciences Corp
|
3,997,925 | $361,652,295 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
3,477,472 | $299,375,563 | |
| 5 | BSX |
Boston Scientific Corp
|
4,987,748 | $212,877,084 | |
| 6 | GKOS |
GLAUKOS Corp
|
1,390,017 | $194,268,775 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
2,367,032 | $151,513,717 | |
| 8 | PEN |
Penumbra Inc
|
448,763 | $141,696,917 |
All Filings in PFSA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,637 | 30,844 | Shares | Defined | 2026-05-15 | |
| 2022-12-31 NVAC | — | 344,217 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 NVAC | — | 383,501 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 NVAC | — | 383,832 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 NVAC | — | 383,833 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||